Nanomedicine in Gene Therapy and Immunotherapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 20 December 2025 | Viewed by 2236
Special Issue Editor
Special Issue Information
Dear Colleagues,
Nanomedicine has emerged as a promising field, offering innovative solutions for targeted gene therapy and immunotherapy as new therapies for various diseases. By harnessing the unique properties of nanomaterials, researchers aim to overcome the limitations of conventional therapies and enhance treatment efficacy and safety. This Special Issue seeks to showcase cutting-edge research and developments in the application of nanomedicine to gene therapy and immunotherapy. We invite contributions that explore the design, synthesis, and characterization of novel nanomaterials for drug delivery, gene delivery, genome editing, and immune modulation. This Special Issue will focus on the design of novel delivery vectors, new applications of nanomedicines, and translational aspects of nanomedicine, including preclinical studies, clinical trials, and regulatory considerations. Potential topics include nanocarriers for targeted gene delivery, non-viral vectors for CRISPR-Cas9 delivery, nanoparticle-mediated immunotherapy, nanomedicine-enabled immunomodulation, and many others. We encourage interdisciplinary collaborations and welcome submissions from diverse fields, including chemistry, materials science, biomedical engineering, biology, immunology, and clinical medicine.
Dr. Ruosen Xie
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- drug delivery
- gene delivery
- genome editing
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
